NYSE: TEVA
Teva Pharmaceutical Industries Ltd Stock Ownership

Insider buying vs selling

Have Teva Pharmaceutical Industries Ltd insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Hafrun FridriksdottirExecutive VP Global R&D2021-08-1050,860$9.95
$506.01kSell
Eric DrapeExecutive VP Global Operations2021-05-2140,000$11.01
$440.32kSell
Eric DrapeExecutive VP Global Operations2021-05-1119,804$10.22
$202.42kSell
David Matthew StarkExec. VP Chief Legal Officer2021-05-1137,884$10.22
$387.14kSell
Hafrun FridriksdottirExecutive VP Global R&D2021-05-1119,066$10.22
$194.84kSell
Mark SabagSee "Remarks" below2021-03-16127,244$11.22
$1.43MSell
Brendan P. 1. OgradyEVP North America Commercial2021-03-0511,436$10.54
$120.58kSell
Richard DaniellExec. VP European Commercial2021-03-047,513$10.58
$79.52kSell
Hafrun FridriksdottirExecutive VP Global R&D2021-03-049,515$10.57
$100.54kSell
David Matthew StarkExec. VP Chief Legal Officer2021-03-0413,930$10.57
$147.18kSell

1 of 5

TEVA insiders have sold more... subscribe to Premium to read more.
Ownership

TEVA Shareholders

What type of owners hold Teva Pharmaceutical Industries Ltd stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Capital Research Global Investors10.78%118,876,651$1.01BInstitution
Berkshire Hathaway Inc3.88%42,789,295$364.14MInstitution
Blackrock Inc3.68%40,541,845$345.01MInstitution
Abrams Capital Management LP2.18%24,046,356$204.63MInstitution
Migdal Insurance Financial Holdings Ltd1.93%21,284,555$181.13MInstitution
Menora Mivtachim Holdings Ltd1.77%19,564,520$166.49MInstitution
Clal Insurance Enterprises Holdings Ltd1.60%17,658,566$150.27MInstitution
State Street Corp1.59%17,533,567$149.21MInstitution
Phoenix Holdings Ltd1.28%14,170,801$120.59MInstitution
Susquehanna International Group Llp0.99%10,924,962$92.97MInstitution

1 of 3

Teva Pharmaceutical Industries Ltd Stock Ownership FAQ

Who owns Teva Pharmaceutical Industries Ltd?

Teva Pharmaceutical Industries Ltd (NYSE: TEVA) is owned by 47.75% institutional shareholders, 0.67% Teva Pharmaceutical Industries Ltd insiders, and 51.57% retail investors. Capital Research Global Investors is the largest individual Teva Pharmaceutical Industries Ltd shareholder, owning 118.88M shares representing 10.78% of the company. Capital Research Global Investors's Teva Pharmaceutical Industries Ltd shares are currently valued at $1.01B.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.